Xeljanz 5 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FY5QY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,056
Award facts
- Contract value 100% obligated
- $10,056.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,056.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of XELJANZ 5 MG tablets (60-count units). The contract, with an ultimate completion date of January 26, 2026, represents a competitively awarded, non-set-aside order executed under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., which rebranded from AmerisourceBergen in recent years.
This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999 indefinite delivery contract with DLA Troop Support Medical, valued through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs. The contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare systems, and other federal medical institutions worldwide. XELJANZ (tofacitinib) is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the diverse therapeutic needs across the military healthcare system that this contract vehicle supports.
Quick answers
Who was awarded contract SPE2DR26FY5QY?
SPE2DR26FY5QY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FY5QY worth?
The government has obligated $10,056 on SPE2DR26FY5QY.
Is contract SPE2DR26FY5QY an order under another contract?
Yes. SPE2DR26FY5QY is a delivery order under SPE2DR25D1006, an indefinite delivery contract.
Was contract SPE2DR26FY5QY competed?
The extent of competition for SPE2DR26FY5QY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award